Arbemnifosbuvir sulfate

N/A

Report date: 2025/12/26 10:31:26
NME

Base Information

Drug NameArbemnifosbuvir sulfate
Drug Alias NameAT-752AT-281
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Nucleoside analogues
Mechanisms of ActionBacterial DNA-directed RNA polymerase inhibitors
TargetsBacterial DNA-directed RNA polymerase
Therapy Area/IndicationsDengue
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesVietnamTaiwan +[12] 
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesAtea Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesAtea Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsDengue
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A